Catalyst Wire Dossier Catalyst Wire Dossier

TN-401

· Tenaya Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TN-401, covering 2025-02-06 to 2025-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC [Phase 1]

See pricing